Presently we are making applications to health canada to have our products sold in Canada. Once approved we would then be able to start initially selling the products on our website
Xilive is an early stage cancer drug and is not FDA approved. Prior to any clinical trials, the company wants to sort out its patents and to make certain it is patentable. Once we get a confirmation this information will be made public.